Investing.com -- Ramaco Resources Inc (NASDAQ:METC) stock rose 5.4% in after-hours trading Tuesday following the company’s announcement of a $100 million share repurchase program.

Investing.com -- UiPath Inc. (NYSE:PATH) stock gained 4.2% in after-hours trading Tuesday following the announcement that the company will be added to the S&P MidCap 400 index.

In its year-ahead outlook, the bank set end-2026 targets of 3,700 for TOPIX and 55,500 for the Nikkei Average, arguing that the underlying environment should remain favorable if its main scenario ...

Investing.com -- Hyperscale Data Inc (AMEX:GPUS) stock fell 7.6% in after-hours trading Friday following the company’s announcement of a new "at-the-market" equity offering program that could dilute ...

Investing.com -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) stock plummeted 46% in premarket trading Tuesday after the company disclosed that the FDA has recommended conducting a second Phase ...

Investing.com -- Organogenesis Holdings Inc (NASDAQ:ORGO) stock rose 1.9% in after-hours trading Tuesday after the regenerative medicine company announced it has begun a rolling submission of a ...

Elong Power Holding Ltd (NASDAQ:ELPW) stock plunged 18.5% on Tuesday after the company announced plans to implement a 16-for-1 reverse stock split, a move aimed a ...

Investing.com-- U.S. stock index futures were little changed on Monday evening after Wall Street closed higher for a third ...

For T1 Energy, this deal represents a continuation of its commercial strategy to offer customers a traceable and reliable ...

Campbell’s Co stock has reached a new 52-week low, trading at $27.85. According to InvestingPro data, the stock is currently at $28.98, just slightly above its 52-week low of $28.53. This marks a ...

Investing.com -- Highway Holdings Limited (NASDAQ:HIHO) stock surged 87.8% Tuesday after the company announced it signed a letter of intent to acquire a 51% stake in German-based Regent-Feinbau ...

Investing.com -- CASI Pharmaceuticals Inc (NASDAQ:CASI) stock surged 10.1% Tuesday in after-hours trade after the clinical-stage biopharmaceutical company received an extension from the Nasdaq ...